About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Alzheimer's Disease Clinical Trials in Houston | 155 Studies

Clinical Trials Alzheimer's DiseaseHouston

Alzheimer's Disease Clinical Trials in Houston

Find 155 clinical trials for alzheimer's disease near Houston, Texas. Connect with research centers in your area.

All Alzheimer's Disease trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 121-140 of 155 trials

CompletedSafety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on DonepezilThe purpose of this study is to determine if Dimebon is safe and effective in patients with mild to moderate Alzheimer's disease on Donepezil.NCT00829374·Phoenix, Arizona and 100 others

Alzheimer's Disease Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedCholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease StudyCLASP is a research study to investigate the safety and effectiveness of simvastatin (a cholesterol lowering drug or statin) to slow the progression of Alzheimer's disease (AD).NCT00053599·Birmingham, Alabama and 43 others

TerminatedOpen-Label Treatment With MPC-7869 for Patients With Alzheimer's Who Previously Participated in an MPC-7869 ProtocolOpen-label treatment with MPC-7869 for participants in a previous randomized study.NCT00380276·Alabaster, Alabama and 89 others

CompletedA Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's DiseaseThe purpose of this study is to evaluate the efficacy and safety of PF 04494700 in participants with mild to moderate Alzheimer's disease.NCT00566397·Phoenix, Arizona and 61 others

CompletedA Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)This study is done to find out whether the medicine, semaglutide, has a positive effect on early Alzheimer's disease.NCT04777396·Phoenix, Arizona and 446 others

SuspendedA Study of Sodium Oligomannate (GV-971) in Participants With Mild to Moderate Alzheimer's DiseaseThe purpose of this study is to evaluate the safety, tolerability and efficacy of GV-971 in mild to moderate Alzheimer's disease.NCT04520412·Gilbert, Arizona and 170 others

CompletedRosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's DiseaseRosiglitazone (RSG) has been tested in clinical studies and is approved by the FDA as a treatment for type II diabetes mellitus, a disease that occurs when the body is unable to…NCT00348309·Litchfield Park, Arizona and 248 others

CompletedResveratrol for Alzheimer's DiseaseResveratrol is derived from plants and is found in highest levels in red wine and the skin of red grapes.NCT01504854·Phoenix, Arizona and 25 others

WithdrawnSafety Study of Sargramostim in Treating Patients With Mild Cognitive Impairment Due to Alzheimer's DiseasePrimary Objective: To compare the effect of repeat doses of Leukine to placebo administered subcutaneously (SC) on established cortical amyloid load in patients with mild…NCT02667496·Houston, Texas

RecruitingA Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)The main purpose of this study is to evaluate whether treatment with donanemab slows the progression of cognitive (how we think, learn, remember, pay attention, and make…NCT07589595·Chandler, Arizona and 71 others

TerminatedA Study to Evaluate the Safety, Tolerability, and Efficacy of Long-Term Gantenerumab Administration in Participants With Alzheimer's Disease (AD)This is an open-label, multicenter, rollover study to evaluate the safety, tolerability, and efficacy of long-term administration of open-label gantenerumab in participants with…NCT04374253·Phoenix, Arizona and 267 others

CompletedMemory Improvement Through Nicotine Dosing (MIND) StudyThe purpose of the study is to see if daily transdermal nicotine is able to produce a significant cognitive, clinical and functional improvement in participants with MCI.NCT02720445·Scottsdale, Arizona and 35 others

CompletedAlzheimer's Disease Neuroimaging Initiative Grand OpportunityThe purpose of this study is to build upon the information obtained in the original Alzheimer's Disease Neuroimaging Initiative (ADNI1), to examine how brain imaging technology…NCT01078636·Birmingham, Alabama and 54 others

Active not recruitingPhase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD)This AR1001-ADP3-US01 protocol is a double-blind, randomized, placebo-controlled, multi- center, parallel-group comparison pivotal Phase 3 study to evaluate the efficacy and…NCT05531526·Phoenix, Arizona and 197 others

Active not recruitingA Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)The purpose of this study is to measure the difference in time to developing or worsening memory, thinking, or functional problems due to Alzheimer's disease occurring in…NCT06653153·Birmingham, Alabama and 261 others

CompletedRegistry of Amyloid Positive Patients for Alzheimer's Disease Drug Research TrialsThis registry will be used to identify patients who have etiology diagnosed or suspected to be Alzheimer's disease and positive amyloid scans, and have indicated their interest in…NCT02918539·Glendale, Arizona and 74 others

Active not recruitingA Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6)This study will investigate different donanemab dosing regimens and their effect on the frequency and severity of ARIA-E in adults with early symptomatic Alzheimer's disease (AD)…NCT05738486·Chandler, Arizona and 48 others

CompletedAlzheimer's Disease Neuroimaging Initiative 2The purpose of this study is to build upon the information obtained in the original Alzheimer's Disease Neuroimaging Initiative (ADNI1) and ADNI-GO (Grand Opportunity; a study…NCT01231971·Birmingham, Alabama and 57 others

TerminatedA Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205The primary objective is to evaluate the safety and tolerability of aducanumab over 100 weeks of treatment after a wash-out period imposed by discontinuation of feeder studies in…NCT04241068·Birmingham, Alabama and 296 others

TerminatedAn Innovative Platform for Objective Monitoring of Instrumental Activities of Daily LivingDifficulties in performing instrumental activity of daily living (IADL) is often an indicator of cognitive decline in older adults, and monitoring IADL and daily functioning can…NCT05703490·Houston, Texas

PreviousPage 7 of 8Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia